Studying the system-level involvement of MicroRNAs in parkinson's disease

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Chatterjee, Paulami ^a   Bhattacharyya, Malay ^b   Bandyopadhyay, Sanghamitra ^c   Roy, Debjani ^a  

^a BOSE INSTITUTE   (India)

^b UNIVERSITY OF KALYANI   (India)

^c INDIAN STATISTICAL INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN SERUM ALBUMIN; MESSENGER RNA; MICRORNA; MICRORNA 92A; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; MITOGEN ACTIVATED PROTEIN KINASE KINASE;

ARTICLE; DISEASE COURSE; DRUG TARGETING; GENE EXPRESSION; GENE FUNCTION; GENE REGULATORY NETWORK; GENETIC CONSERVATION; GENETIC DATABASE; HUMAN; MICROARRAY ANALYSIS; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; SIGNAL TRANSDUCTION; SYSTEM ANALYSIS; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOLOGY;

CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PARKINSON DISEASE; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84898617944     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093751     Document Type: Article

References (81)

1. Fitzgerald JC, Plun-Favreau H (2008) Emerging pathways in genetic Parkinson's disease: autosomal-recessive genes in Parkinson's disease-a common pathway? FEBS Journal 275(23): 5758-5766.
2. Wakabayashi K, Tanji K, Mori F, Takahashi H (2007) The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates. Neuropathology 27(5): 494-506. (Pubitemid 47459715)
3. Jankovic J (2008) Parkinson's disease: clinical features and diagnosis. Journal of Neurology, Neurosurgery and Psychiatry 79(4): 368-376. (Pubitemid 351441488)
4. Savitt JM, Dawson VL, Dawson TM (2006) Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest 116: 1744-1754. (Pubitemid 44033293)
5. Esposito E, Cuzzocrea S (2010) New therapeutic strategy for Parkinson's and Alzheimer's disease. Curr Med Chem 17(25): 2764-2774.
6. Khoo SK, Petillo D, Kang UJ, Resau JH, Berryhill B, et al. (2012) Plasma-based Circulating MicroRNA Biomarkers for Parkinson's Disease. J Parkinsons Dis 2(4): 321-31.
7. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2): 215-233.
8. Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, et al. (2007) A microRNA feedback circuit in midbrain dopamine neurons. Science 317(5842): 1220-1224.
9. Zovoilis A, Agbemenyah HY, Agis-Balboa RC, Stilling RM, Edbauer D, et al. (2011) microRNA-34c is a novel target to treat dementias. The EMBO Journal 30: 4299-4308.
10. Gaughwin PM, Ciesla M, Lahiri N, Tabrizi SJ, Brundin P, et al. (2011) HsamiR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease. Human Molecular Genetics 20: 2225-2237.
11. Yang N, Kaur S, Volinia S, Greshock J, Lassus H, et al. (2008) MicroRNA microarray identifies let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res 68:10307-10314
12. Zaret KS, Carroll JS (2011) Pioneer transcription factors: Establishing competence for gene expression. Genes Dev 25(21): 2227-2241.
13. Bandyopadhyay S, Bhattacharyya M (2009) Analyzing miRNA co-expression networks to explore TF-miRNA regulation. BMC Bioinformatics 10: 163.
14. Shalgi R, Lieber D, Oren M, Pilpel Y (2007) Global and local architecture of the mammalian microRNA-transcription factor regulatory network. PLoS Comput Biol 3(7): e131.
15. Delfino KR, Rodriguez-Zas SL (2013) Transcription factor-microRNA-target gene networks associated with ovarian cancer survival and recurrence. PLoS ONE 8(3): e58608.
16. Aguda BD (2013) Modeling microRNA-transcription factor networks in cancer. Adv Exp Med Biol 774: 149-67.
17. Sengupta D, Bandyopadhyay S (2013) Topological patterns in microRNA-gene regulatory network: studies in colorectal and breast cancer. Mol Biosyst 9(6): 1360-71.
18. Sun J, Gong X, Purow B, Zhao Z (2012) Uncovering microRNA and transcription factor mediated regulatory networks in glioblastoma. PLoS Comput Biol 8: e1002488.
19. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proceedings of the National Academy of Sciences of the United States of America 98: 5116-5121. (Pubitemid 32397092)
20. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4(5): P3.
21. Al-Shahrour F, Minguez P, Tarraga J, Medina I, Alloza E, et al. (2007) FatiGO+: a functional profiling tool for genomic data. Integration of functional annotation, regulatory motifs and interaction data with microarray experiments. Nucleic Acids Res 35: W91-96.
22. Kisby GE, Spencer PS (2013) Parkinsonism and cancer. JAMA Neurol 70(3):414-5.
23. Chen Y, Dorn GW (2013) PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria. Science 340: 471-475.
24. Wang J, Lu M, Qiu C, Cui Q (2009) TransmiR: a transcription factormicroRNA regulation database. Nucleic Acids Res (Database Issue) 38:D119-D122.
25. Sutherland GT, Matigian NA, Chalk AM, Anderson MJ, Silburn PA, et al. (2009) A cross-study transcriptional analysis of Parkinson's disease. PloS ONE 4(3): e4955.
26. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11): 2498-504. (Pubitemid 37428274)
27. Yip KY, Yu H, Kim PM, Schultz M, Gerstein M (2006) The tYNA platform for comparative interactomics: a web tool for managing, comparing and mining multiple networks. Bioinformatics 22(23): 2968-70. (Pubitemid 44811577)
28. Barabasi AL, Albert R (1999) Emergence of scaling in random networks. Science 286(5439): 509-512.
29. Barabasi AL, Oltvai ZN (2004) Network biology: understanding the cell's functional organization. Nat Rev Genet 5(2): 101-113. (Pubitemid 38160277)
30. Watts DJ, Strogatz SH (1998) Collective dynamics of 'small-world' networks. Nature 393(6684): 440-442. (Pubitemid 28292183)
31. Goh KI, Oh E, Jeong H, Kahng B, Kim D (2002) Classification of scale-free networks. Proc. Natl. Acad. Sci 99: 12583-12588.
32. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, et al. (2002) The human genome browser at UCSC. Genome Res 12(6): 996-1006. (Pubitemid 34662293)
33. Siepel A, Bejerano G, Pedersen JS, Hinrichs A, Hou M, et al. (2005) Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 15: 1034-1050. (Pubitemid 41126859)
34. Kiezun A, Artzi S, Modai S, Volk N, Isakov O, et al. (2012) miRviewer: A multispecies microRNA homologous viewer. BMC Research Notes 5: 92.
35. Griffiths-Jones S (2010) miRBase: microRNA sequences and annotation. Curr Protoc Bioinformatics 12(12.9): 1-10.
36. Artzi S, Kiezun A, Shomron N (2008) miRNAminer: a tool for homologous microRNA gene search. BMC Bioinformatics 9: 39.
37. Mongroo PS, Rustgi AK (2010) The role of the miR-200 family in epithelialmesenchymal transition. Cancer Biol Ther 2010, 10: 219-222.
38. Choi PS, Zakhary L, Choi WY, Caron S, Alvarez-Saavedra E, et al. (2008) Members of the miRNA-200 family regulate olfactory neurogenesis. Neuron 57: 41-55.
39. Du ZW, Ma LX, Phillips C, Zhang SC (2013) miR-200 and miR-96 families repress neural induction from human embryonic stem cells. Development 140: 2611-8.
40. Masashi Abe and Nancy M . Bonini (2013) MicroRNAs and Neurodegeneration: Role and Impact. Trends Cell Biol 23(1): 30-36.
41. Yu J, Ohuchida K, Mizumoto K, Sato N, Kayashima T, et al. (2010) MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation. Mol Cancer 9:169.
42. Xu L, Li Q, Xu D, Wang Q, An Y, et al. (2014) has-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration. Int J Oncol 44(2):459-66.
43. Shi WY, Liu KD, Xu SG, Zhang JT, Yu LL, et al. (2014) Gene expression analysis of lung cancer. Eur Rev Med Pharmacol Sci 18(2):217-28.
44. Zhang N, Su Y, Xu L (2013) Targeting PKCe by miR-143 regulates cell apoptosis in lung cancer. FEBS Lett 587(22):3661-7.
45. Xi Y, Formentini A, Chien M, Weir DB, Russo JJ, et al. (2006) Prognostic Values of microRNAs in Colorectal Cancer. Biomark Insights 2:113-121.
46. Xue Q, Sun K, Deng HJ, Lei ST, Dong JQ, et al. (2014) MicroRNA-338-3p Inhibits Colorectal Carcinoma Cell Invasion and Migration by Targeting Smoothened. Jpn J Clin Oncol 44(1):13-21.
47. Han Y, Chen J, Zhao X, Liang C, Wang Y, et al. (2011) MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS ONE 6(3):e18286.
48. Xie P, Xu F, Cheng W, Gao J, Zhang Z, et al. (2012) Infiltration related miRNAs in bladder urothelial carcinoma. J Huazhong Univ Sci Technolog Med Sci 32(4):576-80.
49. Yuan L, Chu H, Wang M, Gu X, Shi D, et al. (2013) Genetic variation in DROSHA 39UTR regulated by hsa-miR-27b is associated with bladder cancer risk. PLoS ONE 8(11):e81524.
50. Wee EJ, Peters K, Nair SS, Hulf T, Stein S, et al. (2012) Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-miR-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer. Oncogene 31(38):4182-95.
51. Uhlmann S, Mannsperger H, Zhang JD, Horvat EA , Schmidt C, et al. (2012) Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer. Mol Syst Biol 8:570.
52. Liu SG, Qin XG, Zhao BS, Qi B, Yao WJ, et al. (2013) Differential expression of miRNAs in esophageal cancer tissue. Oncol Lett 5(5):1639-1642.
53. Su H, Jin X, Zhang X, Xue S, Deng X, et al. (2014) Identification of microRNAs involved in the radio resistance of esophageal cancer cells. Cell Biol Int 38(3):318-25.
54. Song H, Liu Y, Pan J, Zhao ST (2013) Expression profile analysis reveals putative prostate cancer-related microRNAs. Genet Mol Res 12(4):4934-43.
55. Yu T, Wang XY, Gong RG, Li A, Yang S, et al. (2009) The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. J Exp Clin Cancer Res 28:64.
56. Ma D, Zhang YY, Guo YL, Li ZJ, Geng L (2012) Profiling of microRNAmRNA reveals roles of microRNAs in cervical cancer. Chin Med J (Engl) 125(23):4270-6.
57. Chiang Y, Zhou X, Wang Z, Song Y, Liu Z, et al. (2012) Expression levels of microRNA-192 and-215 in gastric carcinoma. Pathol Oncol Res 18(3):585-91.
58. Lee JW, Park YA, Choi JJ, Lee YY, Kim CJ, et al. (2011) The expression of the miRNA-200 family in endometrial endometrioid carcinoma. Gynecol Oncol 120(1):56-62.
59. Chen Z, Ma T, Huang C, Zhang L, Xu T, et al. (2014) MicroRNA-148a: a potential therapeutic target for cancer. Gene 533(1):456-7.
60. Nurul-Syakima AM, Yoke-Kqueen C, Sabariah AR, Shiran MS, Singh A, et al. (2011) Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers. Int J Mol Med 28(3):327-36.
61. Lu Y, Ryan SL, Elliott DJ, Bignell GR, Futreal PA, et al. (2009) Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma. PLoS ONE 4(7):e6159.
62. Zanetti R, Rosso S, Loria DI (2007) Parkinson's disease and cancer. Cancer Epidemiol Biomarkers Prev 16(6):1081. (Pubitemid 46984941)
63. Vaishnavi V, Manikandan M, Tiwary BK, Munirajan AK (2013) Insights on the functional impact of microRNAs present in autism-associated copy number variants. PLoS ONE 8(2):e56781.
64. Slaby O (2013) MiR-190 leads to aggressive phenotype of neuroblastoma through indirect activation of TrkB pathway. Med Hypotheses 80(3):325-6.
65. Xie YF, Shu R, Jiang SY, Liu DL, Zhang XL (2011) Comparison of microRNA profiles of human periodontal diseased and healthy gingival tissues. Int J Oral Sci 3(3):125-34.
66. Bockmeyer CL, Maegel L, Janciauskiene S, Rische J, Lehmann U, et al. (2012) Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression. J Heart Lung Transplant 31(7):764-72.
67. Hsu J, Hanna P, Van Wagoner DR, Barnard J, Serre D, et al. (2012) Whole genome expression differences in human left and right atria ascertained by RNA sequencing. Circ Cardiovasc Genet 5(3):327-35.
68. Matsumoto S, Sakata Y, Suna S, Nakatani D, Usami M, et al. (2013) Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circ Res 113(3):322-6.
69. Taguchi YH, Murakami Y (2013) Principal component analysis based feature extraction approach to identify circulating microRNA biomarkers. PLoS ONE 8(6): e66714.
70. Ohyagi-Hara C, Sawada K, Kamiura S, Tomita Y, Isobe A, et al. (2013) miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin a5 expression. Am J Pathol 182(5):1876-89.
71. Taurino C, Miller WH, McBride MW, McClure JD, Khanin R, et al. (2010) Gene expression profiling in whole blood of patients with coronary artery disease. Clin Sci (Lond) 119(8):335-43.
72. Lu M, Zhang Q, Deng M, Miao J, Guo Y, et al. (2008) An Analysis of Human MicroRNA and Disease Associations. PLoS ONE 3(10): e3420.
73. Martins M, Rosa A, Guedes LC, Fonseca BV, Gotovac K, et al. (2011) Convergence of miRNA expression profiling, alpha-synuclein interacton and GWAS in Parkinson's disease. PLoS ONE 14(10): e25443.
74. Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA (2006) The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med 147: 126-132. (Pubitemid 43288168)
75. Gubian S, Sewer A (2012) ExiMiR: R functions for the normalization of Exiqon miRNA array data. R package version 2.0.0.
76. Satoh J, Tabunoki H (2011) Comprehensive analysis of human microRNA target networks. BioData Mining 4: 17.
77. Vergoulis T, Vlachos IS, Alexiou P, Georgakilas G, Maragkakis M, et al. (2012) TarBase 6.0: Capturing the Exponential Growth of miRNA Targets with Experimental Support. Nucleic Acids Res 14(Database issue):9.
78. Fowlkes EB, Mallows CL (1983) A Method for Comparing Two Hierarchical Clusterings. Journal of the American Statistical Association 78: 553-569.
79. Rand WM (1971) Objective criteria for the evaluation of clustering methods. Journal of the American Statistical Association 66(336): 846-850.
80. Ruan J, Dean AK, Zhang W (2010) A general co-expression network-based approach to gene expression analysis: comparison and applications. BMC Syst Biol 7:8
81. Lee H, Hsu A, Sajdak J, Qin J, Pavlidis P (2004) Coexpression analysis of human genes across many microarray data sets. Genome Res 14(6):1085-94. (Pubitemid 38811545)